Breast Cancer Biomarker Changes and Correlations with HER2 Change in ER Positive, HER2 Negative Breast Cancers Treated with Neoadjuvant Endocrine Therapy

被引：0
作者：
Huang, Wei [1 ]
Tyburski, Haley [2 ]
Finkelman, Brian [3 ]
Turner, Bradley [3 ]
Weiss, Anna [3 ]
Dhakal, Ajay [4 ]
Skinner, Kristin [3 ]
Hicks, David [3 ]
Zhang, Huina [3 ]
机构：
[1] Penn State Hlth Milton S Hershey Med Ctr, Hershey, PA USA
[2] Univ Rochester, Rochester, NY USA
[3] Univ Rochester, Med Ctr, Rochester, NY USA
[4] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
146
引用
收藏
页码：S175 / S176
页数：2
相关论文
共 50 条
  • [21] Synthetic lethal strategies in ER/HER2 negative breast cancers
    Tutt, A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 185 - 185
  • [22] HER2 equivocal breast cancer and neoadjuvant therapy: Is response similar to HER2-positive or HER2-negative tumors?
    Landmann, Alessandra
    Farrugia, Daniel J.
    Diego, Emilia
    Bonaventura, Marguerite
    Soran, Atilla
    Johnson, Ronald
    Dabbs, David J.
    Clark, Beth
    Brufsky, Adam
    Davidson, Nancy E.
    Lembersky, Barry C.
    Jankowitz, Rachel Catherine
    Puhalla, Shannon
    Ahrendt, Gretchen M.
    McAuliffe, Priscilla F.
    Bhargava, Rohit
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Targeted therapy for HER2 positive breast cancer
    Incorvati, Jason A.
    Shah, Shilpan
    Mu, Ying
    Lu, Janice
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [24] Sparing chemotherapy with dual HER2 blockade in combination with endocrine therapy for advanced HER2 positive breast cancer
    Werutsky, Gustavo
    Reinert, Tomas
    Fay, Andre Poisl
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S573 - S576
  • [25] Targeted therapy for HER2 positive breast cancer
    Jason A Incorvati
    Shilpan Shah
    Ying Mu
    Janice Lu
    Journal of Hematology & Oncology, 6
  • [26] Adjuvant therapy in breast cancer HER2 positive
    Olivito, V.
    De Simone, R.
    La Gattuta, G.
    Lucia, M.
    Dima, G.
    Talarico, R.
    Filippelli, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII146 - VII146
  • [27] HER2 equivocal breast cancer that is positive by alternative probe HER2 FISH are classified as HER2 negative by Oncotype DX
    Tozbikian, Gary H.
    Zynger, Debra L.
    BREAST JOURNAL, 2018, 24 (04) : 535 - 540
  • [28] Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts
    Barbieri, E.
    Piacentini, F.
    Dieci, M. V.
    Ficarra, G.
    Bettelli, S.
    Conte, P.
    Guarneri, V.
    CANCER RESEARCH, 2011, 71
  • [29] HER2 up-regulation with neoadjuvant endocrine therapy in patients with hormone receptor-positive, HER2-negative breast cancer
    Chaudhary, Lubna N.
    Jorns, Julie
    Gonyo, MaryBeth
    Kong, Amanda
    Peck, Amy R.
    Sun, Yunguang
    Bergom, Carmen
    Banarjee, Anjishnu
    Chitambar, Christopher
    Rui, Hallgeir
    CANCER RESEARCH, 2020, 80 (04)
  • [30] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
12345